Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
Amor Salah, Consulting Associate at MetaQare IntelliHealth, shared a post on LinkedIn about a recent article by Meghan Caylor Vallejo et al, published in Springer Nature, adding:
“2026 NCS/SCCM Guideline Update on Antithrombotic-Associated ICH.
This focused guideline update from the Neurocritical Care Society (NCS) and Society of Critical Care Medicine (SCCM) provides evidence-based recommendations using GRADE methodology for managing acute antithrombotic-associated intracranial hemorrhage (ICH) in adult patients.
Key Recommendations:
1. Factor Xa Inhibitor Reversal:
The panel conditionally recommends 4-factor prothrombin complex concentrate (4F-PCC) over andexanet alfa for both spontaneous intraparenchymal hemorrhage (IPH) and traumatic ICH. Although andexanet alfa improves hemostatic efficacy, meta-analyses show no mortality or functional outcome benefits. Crucially, andexanet alfa increases thrombotic risk. Combining 4F-PCC and andexanet alfa is explicitly advised against.
2. Platelet Transfusion in Antiplatelet Use:
- Spontaneous IPH without Surgery: Suggests against platelet transfusion, as evidence shows no mortality benefit and potential functional harm.
- Spontaneous IPH with Surgery: Suggests platelet transfusion for patients on aspirin undergoing neurosurgical intervention.
- Traumatic ICH: Issues no recommendation due to very low certainty evidence.
3. Desmopressin (DDAVP):
The panel makes no recommendation regarding desmopressin in antiplatelet-associated ICH due to insufficient evidence of clinical efficacy.
4. Small Spontaneous IPH:
Makes no recommendation on reversing anticoagulant effects in small IPH (<5–10 mL) due to lack of direct evidence.
5. Viscoelastic Hemostatic Assays (VHAs):
Conditionally suggests VHA-guided (TEG/ROTEM) management in traumatic ICH when available, supported by potential mortality reduction.”
Title: Treatment of Antithrombotic-Associated Intracranial Hemorrhage in Adults: A Focused Guideline Update from the Neurocritical Care Society and the Society of Critical Care Medicine
Authors: Meghan Caylor Vallejo, Lori S. Kennedy, Bradley Dengler, Colleen Barthol, Emilie P. Belley-Cote, Joseph D. Burns, Veda K. Chau, Charlotte Cordonnier, Adam Cuker, Kimia Honarmand, Sherif Hanafy Mahmoud, M. Elizabeth Wilcox and Monisha A. Kumar

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health